C

Cerus Corp
D

CERS

1.65000
USD
-0.10
(-5.71%)
مغلق
حجم التداول
219,680
الربح لكل سهم
-0
العائد الربحي
-
P/E
-15
حجم السوق
306,430,435
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    1.200
    (0.60%)
    202.140 USD
    A
    ADPT
    -0.06500
    (-0.78%)
    8.27000 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NTRA
    -5.740
    (-3.41%)
    162.430 USD
    P
    PSTG
    -2.750
    (-4.05%)
    65.080 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    T
    TDOC
    -1.190
    (-9.38%)
    11.490 USD
    المزيد
الأخبار
المقالات

العنوان: Cerus Corp

القطاع: Healthcare
الصناعة: Medical Devices
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.